Difference between revisions of "Template:Article of the week"

From LIMSWiki
Jump to navigationJump to search
(Updated article of the week text)
(7 intermediate revisions by the same user not shown)
Line 1: Line 1:
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Fig4 Pratt JforElecHthDataMeth2019 7-1.png|240px]]</div>
<div style="float: left; margin: 0.5em 0.9em 0.4em 0em;">[[File:Anx1 WHO 2020 2020.5.png|240px]]</div>
'''"[[Journal:Implementing a novel quality improvement-based approach to data quality monitoring and enhancement in a multipurpose clinical registry|Implementing a novel quality improvement-based approach to data quality monitoring and enhancement in a multipurpose clinical registry]]"'''
'''"[[Journal:Laboratory testing for coronavirus disease (COVID-19) in suspected human cases|Laboratory testing for coronavirus disease (COVID-19) in suspected human cases]]"'''


There is growing interest in the potential for clinical registries that can simultaneously support clinical care, quality improvement (QI), and [[research]]. This multi-purpose model is consistent with the Institute of Medicine’s (IOM’s) vision of a learning health system which “draws research closer to clinical practice by building knowledge development and application into each stage of the health care delivery process.” Gliklich ''et al.'' define a registry as “an organized system that uses observational study methods to collect uniform data (clinical and other) to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves one or more predetermined scientific, clinical, or policy purposes.” Most pediatric chronic illnesses meet the [[National Institutes of Health]]'s (NIH) definition for rare disease, and as such, multi-center registries are especially important to study and improve care for children with chronic diseases. ('''[[Journal:Implementing a novel quality improvement-based approach to data quality monitoring and enhancement in a multipurpose clinical registry|Full article...]]''')<br />
This document provides interim guidance to [[Laboratory|laboratories]] and stakeholders involved in [[COVID-19]] virus laboratory testing of patients. It is based in part on the interim guidance on laboratory testing for [[Middle East respiratory syndrome]] (MERS) coronavirus. [[Information]] on human [[infection]] with the COVID-19 virus is evolving and the [[World Health Organization]] (WHO) continues to monitor developments and revise recommendations as necessary. This document will be revised as new information becomes available. Feedback is welcome and can be sent to WHElab@who.int. The virus has now been named SARS-CoV-2 by the International Committee of Taxonomy of Viruses (ICTV)(2). This virus can cause the disease named coronavirus disease 2019 (COVID-19). WHO refers to the virus as COVID-19 virus in its current documentation. ('''[[Journal:A security review of local government using NIST CSF: A case study|Full article...]]''')<br />
<br />
<br />
''Recently featured'':
''Recently featured'':
: ▪ [[Journal:Fast detection of 10 cannabinoids by RP-HPLC-UV method in Cannabis sativa L.|Fast detection of 10 cannabinoids by RP-HPLC-UV method in Cannabis sativa L.]]
: ▪ [[Journal:One tool to find them all: A case of data integration and querying in a distributed LIMS platform|One tool to find them all: A case of data integration and querying in a distributed LIMS platform]]
: ▪ [[Journal:What is this sensor and does this app need access to it?|What is this sensor and does this app need access to it?]]
: ▪ [[Journal:What is the "source" of open-source hardware?|What is the "source" of open-source hardware?]]
: ▪ [[Journal:AI meets exascale computing: Advancing cancer research with large-scale high-performance computing|AI meets exascale computing: Advancing cancer research with large-scale high-performance computing]]
: ▪ [[Journal:From command-line bioinformatics to bioGUI|From command-line bioinformatics to bioGUI]]

Revision as of 15:46, 23 March 2020

Anx1 WHO 2020 2020.5.png

"Laboratory testing for coronavirus disease (COVID-19) in suspected human cases"

This document provides interim guidance to laboratories and stakeholders involved in COVID-19 virus laboratory testing of patients. It is based in part on the interim guidance on laboratory testing for Middle East respiratory syndrome (MERS) coronavirus. Information on human infection with the COVID-19 virus is evolving and the World Health Organization (WHO) continues to monitor developments and revise recommendations as necessary. This document will be revised as new information becomes available. Feedback is welcome and can be sent to WHElab@who.int. The virus has now been named SARS-CoV-2 by the International Committee of Taxonomy of Viruses (ICTV)(2). This virus can cause the disease named coronavirus disease 2019 (COVID-19). WHO refers to the virus as COVID-19 virus in its current documentation. (Full article...)

Recently featured:

▪ One tool to find them all: A case of data integration and querying in a distributed LIMS platform
▪ What is the "source" of open-source hardware?
▪ From command-line bioinformatics to bioGUI
Retrieved from "https://www.limswiki.org/index.php?title=Template:Article_of_the_week&oldid=38742"